Why MASLD Lags Behind MAFLD: A Critical Analysis of Diagnostic Criteria Evolution in Metabolic Dysfunction-Associated Liver Diseases

Mohamed Alboraie; Amna Subhan Butt; Alejandro Piscoya; Hang Dao Viet; Bilal Hotayt; Sameer Al Awadhi; Ibrahim Halil Bahcecioglu; Nawal Alkhalidi; Mamun Al Mahtab; Nahum Méndez-Sánchez

doi:10.12659/MSM.945198

30 July 2024 : Review article

Why MASLD Lags Behind MAFLD: A Critical Analysis of Diagnostic Criteria Evolution in Metabolic Dysfunction-Associated Liver Diseases

Mohamed Alboraie

^1AEF*, Amna Subhan Butt^2AEF, Alejandro Piscoya

^3ACE, Hang Dao Viet

^4AE, Bilal Hotayt^5AE, Sameer Al Awadhi^6AE, Ibrahim Halil Bahcecioglu^7AE, Nawal Alkhalidi^8AE, Mamun Al Mahtab^9AE, Nahum Méndez-Sánchez^10AE

DOI: 10.12659/MSM.945198

Med Sci Monit 2024; 30:e945198

Authors information Article notes Copyright and License information

Introduction MAFLD vs MASLD Evidence Goal Missing Planning Problems Execution Issues Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 Limitations of the Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) definition.

Back to the Article

Why MASLD Lags Behind MAFLD: A Critical Analysis of Diagnostic Criteria Evolution in Metabolic Dysfunction-Associated Liver Diseases

Your Privacy